1YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
ICAM-1-IN-1 | 251994-14-6 | 251994-14-6 |
KDM5A-IN-1 | 1905481-36-8 | 1905481-36-8 |
A-196 | 1982372-88-2 | 1982372-88-2 |
ME0328 | ME0328 | 1445251-22-8 |
BI-7273 | CS-2327 | 1883429-21-7 |
MS049 | 1502816-23-0 | 1502816-23-0 |
Dynamin inhibitory peptide | P4 | 251634-21-6 |
HSDVHK-NH2 | P11 | 848644-86-0 |
DynaMin inhibitory peptide, myristoylated | MYR-GLN-PRO-PRO-ALA-SER-ASN-PRO-ARG-VAL-ARG-NH2 | 251634-22-7 |
Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA | 199807-33-5 | 199807-33-5 |
Vedolizumab | 维多珠单抗 | 943609-66-3 |
(Rac)-BAY1238097 | (RAC)-BAY1238097 | 1564268-19-4 |
GSK1379725A | 1802251-00-8 | 1802251-00-8 |
Sirt2-IN-1 | SIRT2-IN-1 | 1862238-00-3 |
HJB97 | 2093391-24-1 | |
INCB054329 | 1628607-64-6 | 1628607-64-6 |
CF53 | CF53 | 1808160-52-2 |
SIRT5 inhibitor 1 | 2166487-21-2 | 2166487-21-2 |
PKC-theta inhibitor | MDK-8650 | 736048-65-0 |
SGC-iMLLT | SGC-IMLLT | 2255338-25-9 |
Nudifloramide | 1-甲基-6-氧代吡啶-3-甲酰胺 | 701-44-0 |
BI-9321 trihydrochloride | BI-9321 trihydrochloride | 2387510-87-2 |
MRK-740 | 化合物 MRK-740 | 2387510-80-5 |
UBCS039 | UBCS039 | 358721-70-7 |
PIN1 inhibitor API-1 | O6-[4-(TRIFLUOROACETAMIDOMETHYL)BENZYL]GUANINE | 680622-70-2 |
GSK467 | 化合物GSK467 | 1628332-52-4 |
TCS 21311 | TCS21311; TCS-21311 | 1260181-14-3 |
GNE-049 | 化合物 T15397 | 1936421-41-8 |
DCP-LA | DCP-LA | 28399-31-7 |
DCPLA-ME | DCPLA-ME | 56687-67-3 |
EB-47 dihydrochloride | EB47; EB-47 | 1190332-25-2 |
BYK204165 | 4-((1-甲基-1H-吡咯-2-基)亚甲基)异喹啉-1,3(2H,4H)-二酮 | 1104546-89-5 |
GNE-781 | GNE-781 | 1936422-33-1 |
GeA-69 | N-(2-(9H-咔唑-1-基)苯基)乙酰胺 | 2143475-98-1 |
JFD00244 | JFD00244 | 96969-83-4 |
Valemetostat tosylate | VALEMETOSTAT TOSYLATE | 1809336-93-3 |
UNC0224 | UNC 0224 | 1197196-48-7 |
UNC0321 | UNC0321 | 1238673-32-9 |
EZM 2302 | GSK 3359088 | 1628830-21-6 |
E-7386 | E-7386 | 1799824-08-0 |
EBI-2511 | 化合物EBI-2511 | 2098546-05-3 |
CBP/EP300-IN-1 | Benzoic acid, 3-[[(1-acetyl-5-methoxy-1H-indol-3-yl)carbonyl]amino]-4-fluoro-, 1,1-dimethylethyl ester | 2443789-32-8 |
Y06036 | Y06036 | 1832671-96-1 |
Y06137 | Y06137 | 2226534-49-0 |
EHMT2-IN-2 | EHMT2-IN-2 | 2230850-47-0 |
BRD7-IN-1 | 化合物BRD7-IN-1 | 2448414-48-8 |
MT1 | MT1 BET INHIBITOR | 2060573-82-0 |
ZL0420 | ZL0420 | 2230496-80-5 |
NCGC00247743 | 1435192-04-3 | 1435192-04-3 |
BAY1238097 | BAY1238097 | 1564268-08-1 |
(R)-BAY1238097 | (R)-BAY1238097 | 1564269-85-7 |
GNA002 | GNA002 | 1385035-79-9 |
A-395 | 化合物A-395 | 2089148-72-9 |
JNJ-64619178 | CS-2829 | 2086772-26-9 |
IACS-9571 hydrochloride | IACS-9571 hydrochloride | 2319611-93-1 |
MOZ-IN-2 | MOZ-IN-2 | 2055397-88-9 |
BET bromodomain inhibitor | 化合物BET BROMODOMAIN INHIBITOR | 1505453-59-7 |
CMPD101 | CMPD101 | 865608-11-3 |
T-3775440 hydrochloride | T-3775440盐酸盐 | 1422535-52-1 |
Fasudil Hydrochloride | 盐酸法舒地尔 | 105628-07-7 |
PROTAC Sirt2 Degrader-1 | 2MG | 2098487-75-1 |
PF-06726304 | PF-06726304 | 1616287-82-1 |
Seclidemstat | SECLIDEMSTAT | 1423715-37-0 |
GSK2807 Trifluoroacetate | GSK2807 Trifluoroacetate | 2245255-66-5 |
QC6352 | QC6352 | 1851373-36-8 |
CAY10602 | 1-(4-氟苯基)-3-(苯磺酰基)-1H-吡咯并[2,3-B]喹喔啉-2-胺 | 374922-43-7 |
SRT 1720 | N-[2-[3-(1-哌嗪基甲基)咪唑并[2,1-B]噻唑-6-基]苯基]-2-喹喔啉甲酰胺 | 925434-55-5 |
Niraparib hydrochloride | MK-4827 | 1038915-64-8 |
Niraparib (R-enantiomer) | MK-4827 (R-enantioMer) | 1038915-58-0 |
Delcasertib | Delcasertib | 949100-39-4 |
SB-218078 | SB218078 | 135897-06-2 |
BAY-299 | BAY-299 | 2080306-23-4 |
GSK8573 | GSK8573 | 1693766-04-9 |
R 59-022 | 化合物 T16709 | 93076-89-2 |
Bisindolylmaleimide X hydrochloride | BISINDOLYLMALEIMIDE X HYDROCHLORIDE (BIM-X HYDROCHLORIDE) | 145317-11-9 |
KDM5-IN-1 | 1628210-26-3 | 1628210-26-3 |
TP-472 | TP-472 | 2079895-62-6 |
SGC2085 | SGC2085 | 1821908-48-8 |
Cl-amidine hydrochloride | N-[(1S)-1-(氨基羰基)-4 -[(2 - 氯-1-亚氨基乙基氨基]丁基]-苯甲酰胺盐酸盐 | 1373232-26-8 |
Hispidin | 6-[(1E)-2-(3,4-二羟基苯基)乙烯基]-4-羟基-2H-吡喃-2-酮 | 555-55-5 |
AZD5153 6-Hydroxy-2-naphthoic acid | AZD5153结晶体(API形式) | 1869912-40-2 |
Lin28-let-7a antagonist 1 | Lin28-IN-1 | 2024548-03-4 |
TPOP146 | 2018300-62-2 | 2018300-62-2 |
GNE-272 | 1936428-93-1 | 1936428-93-1 |
GSK9311 | 1923851-49-3 | 1923851-49-3 |
Histone Acetyltransferase Inhibitor II | 组蛋白乙酰转移酶 抑制剂II | 932749-62-7 |
HA-100 | 1-(5-异喹啉磺酰基)哌嗪盐酸盐 | 84468-24-6 |
GSK 4027 | 化合物 T11495L | 2079896-25-4 |
GSK4028 | 2079886-19-2 | 2079886-19-2 |
D-erythro-Sphingosine | D-鞘氨醇 | 123-78-4 |
PBIT | 2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one | 2514-30-9 |
AK-1 | SIRT2 Inhibitor II, AK-1 | 330461-64-8 |
(S)-JQ-35 | 1349719-98-7 | 1349719-98-7 |
BJE6-106 | BJE6-106 | 1564249-38-2 |
PARP14 inhibitor H10 | PARP14 INHIBITOR H10 | 2084811-68-5 |
MS402 | MS-402 | 1672684-68-2 |
GNE-207 | 化合物 T15399 | 2158266-58-9 |
CMP-5 | 1-(9-ethyl-9H-carbazol-3-yl)-N-(pyridin-2-ylmethyl)methanamine | 880813-42-3 |
KDM5-C70 | ethyl 2-(((2-((2-(dimethylamino)ethyl)(ethyl)amino)-2-oxoethyl)amino)methyl)isonicotinate | 1596348-32-1 |
MM-102 TFA | 1883545-52-5 | 1883545-52-5 |
联系方式